Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Ye Xu's publication output changed over time?
ScholarIQpublication output · 2005–2025
Output grew0% over the shown period — from 1 works in 2005 to 1 in 2025.
1
1
1
3
1
2
1
1
20052008201320152017201820192025
What are the most-cited papers on Ye Xu?
ScholarIQmost cited works
Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment
Ye Xu, Yu Sun, Lei Yao, L. Shi, Yuelong Wu, Tao Ouyang, J. Li, T. Wang, Zhaoqing Fan, Tao Fan, Bo Lin, Liang He, P. Li, Yuntao Xie
Annals of Oncology. 2008182 Citations
KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing
Jie Chen, Yuhui Ou, Yanyan Yang, Wen Li, Ye Xu, Yuntao Xie, Ying Liu
Nature. 2018129 Citations
A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer
Lei Zhang, Ye Xu, Xingyu Jin, Zengwu Wang, Yidi Wu, Deyao Zhao, Gang Chen, Deyu Li, Xiaoxia Wang, Huiqing Cao, Yuntao Xie, Zicai Liang
Breast Cancer Research and Treatment. 2015126 Citations
p53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
Ye Xu, Lihua Yao, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Benyao Lin, Youyong Lu, Yuntao Xie
Clinical Cancer Research. 2005102 Citations
Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
Ye Xu, Limei Diao, yu-ao Chen, Yiqiang Liu, C. Wang, Tao Ouyang, J. Li, T. Wang, Zhaoqing Fan, Tao Fan, Bo Lin, Dajun Deng, Steven A. Narod, Yuxin Xie
Annals of Oncology. 2013102 CitationsOPEN ACCESS
Related on ScholarIQ
Kunming University of Science and Technology
Institution
Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment
Paper
KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing
Paper
A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer
Paper
p53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
Paper
Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
Paper